📰 Stock Code News
Page 36 - Stock Code News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Stock Code. Real-time updates on events, politics, business and more.
January 9, 2023
Media OutReach | 2022 Net Profit Attributable to Shareholders of the Company Expected to be between HK$550 Million and HK$600 Million, Significant Year-on-Year Growth of
January 4, 2023
EASSON HOLDINGS becomes a member of the Hong Kong Association of China Travel Organisers , Preparing for cross-border travel for Chinese residents of Post-covid Period ... | January 4, 2023
January 3, 2023
Lijing Zhou, Senior Vice President of Yangtze Optical Fibre and Cable Joint Stock Limited Company (YOFC), a world
December 31, 2022
WUHAN, China, Dec. 31, 2022 /PRNewswire/ -- Lijing Zhou, Senior Vice President of Yangtze Optical Fibre and Cable Joint Stock Limited Company (YOFC), a world-leading provider of optical fiber
December 30, 2022
EASSON: HONG KONG LAUNCHES NEW VISA SCHEME TO ATTRACT TOP TALENT,EASSON introducing TOP TOLENTS TO HK 30 Dec 2022 06:48 CET ... | December 30, 2022
December 29, 2022
DJ New Huo Tech 2022 Annual Result: Virtual Assets Related Revenue Expanded, Plans to Launch New Platform Sinohope EQS Newswire / 29/12/2022 / 11:37 UTC+8 New Huo Tech 2022 Annual Result: Virtual
December 28, 2022
DJ New Huo Tech to Launch DeFi and Metaverse Thematic Investments EQS Newswire / 28/12/2022 / 10:24 UTC+8 New Huo Tech to Launch DeFi and Metaverse Thematic Investments ?23rd December, 2022
December 22, 2022
Investegate announcements from BioNTech SE, BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China
December 22, 2022
Approximately 11,500 of the companies' mRNA-based COVID-19 vaccine doses arrived on the Chinese Mainland to enable vaccination campaign for German expatriatesVaccines expected to be available in Beijing
December 20, 2022
/PRNewswire/ -- Sirnaomics Ltd. (Stock Code: 2257.HK) (the "Company", together with its subsidiaries, "Sirnaomics" or the "Group"), a leading biopharmaceutical...